2023 Q1 Form 10-Q Financial Statement

#000149315223017616 Filed on May 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $15.89M $3.720M
YoY Change 327.18% 111.63%
Cost Of Revenue $14.07M $3.174M
YoY Change 343.26% 147.39%
Gross Profit $1.819M $545.3K
YoY Change 233.61% 14.92%
Gross Profit Margin 11.45% 14.66%
Selling, General & Admin $5.349M $1.922M
YoY Change 178.36% 288.98%
% of Gross Profit 294.07% 352.45%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $270.3K $59.19K
YoY Change 356.71% 80.4%
% of Gross Profit 14.86% 10.86%
Operating Expenses $5.349M $1.922M
YoY Change 178.36% 288.99%
Operating Profit -$3.530M -$1.377M
YoY Change 156.47% 6937.47%
Interest Expense $69.38K -$130.00
YoY Change -53465.38% -99.72%
% of Operating Profit
Other Income/Expense, Net -$46.32M $49.52K
YoY Change -93639.58% 92.68%
Pretax Income -$49.85M -$1.327M
YoY Change 3656.28% 3189.07%
Income Tax -$190.0K
% Of Pretax Income
Net Earnings -$49.85M -$1.137M
YoY Change 4283.89% 3820.24%
Net Earnings / Revenue -313.73% -30.57%
Basic Earnings Per Share -$40.15 -$101.00
Diluted Earnings Per Share -$40.15 -$95.95K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding 1.242M shares 10.00K shares

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.370M $1.013M
YoY Change 232.69%
Cash & Equivalents $3.100M $1.013M
Short-Term Investments $270.0K
Other Short-Term Assets $987.1K $7.868M
YoY Change -87.45%
Inventory $7.877M $82.64K
Prepaid Expenses
Receivables $2.137M $969.8K
Other Receivables $0.00 $0.00
Total Short-Term Assets $16.95M $9.933M
YoY Change 70.6%
LONG-TERM ASSETS
Property, Plant & Equipment $1.121M $955.2K
YoY Change 17.36%
Goodwill $22.32M
YoY Change
Intangibles $18.08M
YoY Change
Long-Term Investments $2.220M $4.000M
YoY Change -44.5%
Other Assets
YoY Change
Total Long-Term Assets $43.81M $4.955M
YoY Change 784.1%
TOTAL ASSETS
Total Short-Term Assets $16.95M $9.933M
Total Long-Term Assets $43.81M $4.955M
Total Assets $60.75M $14.89M
YoY Change 308.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.015M $172.6K
YoY Change 1067.04%
Accrued Expenses $4.760M $89.15K
YoY Change 5239.32%
Deferred Revenue
YoY Change
Short-Term Debt $1.850M $0.00
YoY Change
Long-Term Debt Due $280.0K
YoY Change
Total Short-Term Liabilities $16.34M $7.885M
YoY Change 107.26%
LONG-TERM LIABILITIES
Long-Term Debt $26.57M $0.00
YoY Change
Other Long-Term Liabilities $6.120M $5.886M
YoY Change 3.97%
Total Long-Term Liabilities $32.69M $5.886M
YoY Change 455.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.34M $7.885M
Total Long-Term Liabilities $32.69M $5.886M
Total Liabilities $49.11M $13.60M
YoY Change 261.13%
SHAREHOLDERS EQUITY
Retained Earnings -$94.81M
YoY Change
Common Stock $106.3M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.96M $1.290M
YoY Change
Total Liabilities & Shareholders Equity $60.75M $14.89M
YoY Change 308.07%

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$49.85M -$1.137M
YoY Change 4283.89% 3820.24%
Depreciation, Depletion And Amortization $270.3K $59.19K
YoY Change 356.71% 80.4%
Cash From Operating Activities -$4.937M -$1.552M
YoY Change 218.14% -4984.83%
INVESTING ACTIVITIES
Capital Expenditures $36.31K -$6.600K
YoY Change -650.11% -63.8%
Acquisitions
YoY Change
Other Investing Activities $180.0K
YoY Change
Cash From Investing Activities $67.20K -$6.600K
YoY Change -1118.21% -63.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $14.60K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $2.384M 1.660M
YoY Change 43.59% 3676.73%
NET CHANGE
Cash From Operating Activities -$4.937M -1.552M
Cash From Investing Activities $67.20K -6.600K
Cash From Financing Activities $2.384M 1.660M
Net Change In Cash -$2.486M 101.7K
YoY Change -2543.65% 76.94%
FREE CASH FLOW
Cash From Operating Activities -$4.937M -$1.552M
Capital Expenditures $36.31K -$6.600K
Free Cash Flow -$4.974M -$1.545M
YoY Change 221.85% -3190.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001892492
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2022Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2022Q1 OCTO Purchase Of Developed Technology
PurchaseOfDevelopedTechnology
usd
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
CY2023Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
usd
CY2022Q1 OCTO Proceeds From Repayments Of Related Part Convertible Debt
ProceedsFromRepaymentsOfRelatedPartConvertibleDebt
usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q1 OCTO Warrants Issued
WarrantsIssued
usd
CY2022Q1 OCTO Original Issue Discount
OriginalIssueDiscount
usd
CY2022Q1 us-gaap Stock Issued1
StockIssued1
usd
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
shares
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
usd
CY2023Q1 OCTO Prepaid Software Deposit
PrepaidSoftwareDeposit
usd
CY2023Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
CY2023Q1 OCTO Accrued Settlement Liability For Equity Holders Of Forever8
AccruedSettlementLiabilityForEquityHoldersOfForever8
usd
CY2022Q4 OCTO Accrued Warrant Liability
AccruedWarrantLiability
usd
CY2022Q4 OCTO Convertible Notes Payable Current Gross
ConvertibleNotesPayableCurrentGross
usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-41033
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
EIGHTCO HOLDINGS INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-2755739
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
200 9th Avenue North
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 220
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Safety Harbor
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
34695
CY2023Q1 dei City Area Code
CityAreaCode
(888)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
765-8933
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
OCTO
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2371949 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3094260 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5580431 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
2850000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
1000000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2137267 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1263552 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
7877339 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4502003 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
987059 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1736145 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
16945925 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
14082131 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1120955 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1321042 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
57769 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
68600 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18080897 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18579986 usd
CY2023Q1 us-gaap Goodwill
Goodwill
22324588 usd
CY2022Q4 us-gaap Goodwill
Goodwill
22324588 usd
CY2023Q1 OCTO Loans Held For Investment
LoansHeldForInvestment
2224252 usd
CY2022Q4 OCTO Loans Held For Investment
LoansHeldForInvestment
2224252 usd
CY2023Q1 us-gaap Assets
Assets
60754386 usd
CY2022Q4 us-gaap Assets
Assets
58600599 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2014659 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2174034 usd
CY2023Q1 OCTO Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
4929680 usd
CY2022Q4 OCTO Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2624518 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44446 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
43950 usd
CY2023Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1850000 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1850000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
5277250 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
5277250 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
277750 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7226700 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7226700 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
16343235 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13919202 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15265 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
26564 usd
CY2023Q1 OCTO Contingent Consideration
ContingentConsideration
6100000 usd
CY2022Q4 OCTO Contingent Consideration
ContingentConsideration
6100000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
82104 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
82104 usd
CY2023Q1 us-gaap Liabilities
Liabilities
49108184 usd
CY2022Q4 us-gaap Liabilities
Liabilities
52789375 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1311 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1311 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1797570 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1797570 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
633602 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
633602 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1797 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
633 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
106251220 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
50617631 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-94809339 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44958199 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
519033 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
467668 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
11962711 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6127733 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
-316509 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-316509 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11646202 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5811224 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60754386 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58600599 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15889715 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3719647 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
14070623 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
3174383 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
1819092 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
545264 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5349431 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1921795 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3530339 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1376531 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2813227 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-129 usd
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
43541211 usd
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
33637 usd
CY2022Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
49519 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-46320801 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
49390 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-49851140 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1327141 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-189997 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-49851140 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1137144 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-126754 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-49851140 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1010390 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-40.15
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-101.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-40.15
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-101.04
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
1241624 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
10000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1241624 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10000 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2171352 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1137144 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1034208 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5811224 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5811224 usd
CY2023Q1 OCTO Stock Issued During Period Value Issuance Of Common Stock To Note Holders
StockIssuedDuringPeriodValueIssuanceOfCommonStockToNoteHolders
7743333 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14600 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
47876820 usd
CY2023Q1 OCTO Stock Issued During Period Value Foreign Currency Translation
StockIssuedDuringPeriodValueForeignCurrencyTranslation
51365 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-49851140 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11646202 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11646202 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-49851140 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1137144 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
626077 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
59192 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2043458 usd
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
43541211 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
608356 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
46705 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-5897 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1482070 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
149484 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3323971 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-28029 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-749086 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
785899 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-159375 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1458 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2305191 usd
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
385232 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4937282 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1551911 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36307 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6595 usd
CY2023Q1 OCTO Purchase Of Developed Technology
PurchaseOfDevelopedTechnology
77491 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
181000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
67202 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6595 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14598 usd
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3150000 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
1687891 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
664389 usd
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
27644 usd
CY2023Q1 OCTO Proceeds From Repayments Of Related Part Convertible Debt
ProceedsFromRepaymentsOfRelatedPartConvertibleDebt
-116300 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2383909 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1660247 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2486171 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
101741 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5580431 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
911194 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3094260 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1012935 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
46492 usd
CY2023Q1 OCTO Warrants Issued
WarrantsIssued
4335611 usd
CY2023Q1 OCTO Original Issue Discount
OriginalIssueDiscount
555000 usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
7743333 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3100000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5600000 usd
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
3100000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_z6RocBfIu7qa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i><span id="xdx_86B_zSKoxNdy46td">Use of Estimates</span>. </i>The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. The Company’s significant estimates used in these consolidated financial statements include, but are not limited to, fair value of warrants, revenue recognition and the determination of the economic useful life of depreciable property and equipment. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
46705 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
46705 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5710040 shares
CY2023Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
29383700 usd
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zd0htoiKVl8h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i><span id="xdx_863_zr7PExFUIbJh">Concentration of Credit Risks</span>. </i>Financial instruments that potentially subject the Company to concentrations of credit risk are cash equivalents and accounts receivable. Cash and cash equivalents are invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. The Company has not experienced any significant losses on its deposits of cash and cash equivalents. In regard to trade receivables, the Company performs ongoing evaluations of its customers’ financial condition as well as general economic conditions and, generally, requires no collateral from its customers. On <span style="background-color: white">March </span> 31, 2023, amount due from one customer totaled approximately <span id="xdx_903_ecustom--ConcentrationRiskPercentage_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zEWqYMOYQEMa" title="Concentration risk percentage">17</span>% of accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
98736 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
27500000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
27500000 usd
CY2023Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2745623 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1871908 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
608356 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
608356 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2137267 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1263552 usd
CY2023Q1 OCTO Advances For Inventory Purchases
AdvancesForInventoryPurchases
295632 usd
CY2022Q4 OCTO Advances For Inventory Purchases
AdvancesForInventoryPurchases
630967 usd
CY2023Q1 us-gaap Prepaid Insurance
PrepaidInsurance
384870 usd
CY2023Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
30726 usd
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
27922 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8146613 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4474081 usd
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
300000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
7877339 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4502003 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
735934 usd
CY2023Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
273155 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
90578 usd
CY2022Q4 OCTO Prepaid Software Deposit
PrepaidSoftwareDeposit
242200 usd
CY2023Q1 OCTO Other Current Assets
OtherCurrentAssets
33402 usd
CY2022Q4 OCTO Other Current Assets
OtherCurrentAssets
36466 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
987059 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1736145 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6616057 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6781752 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5495102 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5460710 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1120955 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1321042 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
270325 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
270325 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
277750 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19236085 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19158594 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1155188 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
578608 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18080897 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18579986 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
578608 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1815342 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
2314431 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
2314431 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
2314431 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
2314431 usd
CY2023Q1 OCTO Finite Lived Intangible Assets Amortization Expense Rolling After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFour
7007831 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18080897 usd
CY2022Q4 us-gaap Goodwill
Goodwill
22324588 usd
CY2023Q1 us-gaap Goodwill
Goodwill
22324588 usd
CY2023Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
210213 usd
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
83504 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1250695 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
386781 usd
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
558632 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
280000 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
481 usd
CY2022Q4 OCTO Accrued Settlement Liability For Equity Holders Of Forever8
AccruedSettlementLiabilityForEquityHoldersOfForever8
469775 usd
CY2023Q1 OCTO Accrued Interest
AccruedInterest
1443375 usd
CY2022Q4 OCTO Accrued Interest
AccruedInterest
825872 usd
CY2023Q1 OCTO Accrued Rent
AccruedRent
787500 usd
CY2022Q4 OCTO Accrued Rent
AccruedRent
525000 usd
CY2023Q1 OCTO Accrued Warrant Liability
AccruedWarrantLiability
469765 usd
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
209019 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
53586 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
4929680 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2624518 usd
CY2023Q1 OCTO Convertible Notes Payable Percentage
ConvertibleNotesPayablePercentage
0 pure
CY2023Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.15 pure
CY2022Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.15 pure
CY2023Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1850000 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1850000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
69375 usd
CY2022 us-gaap Interest Expense
InterestExpense
69375 usd
CY2023Q1 OCTO Convertible Notes Payable Percentage
ConvertibleNotesPayablePercentage
0 pure
CY2022Q4 OCTO Convertible Notes Payable Percentage
ConvertibleNotesPayablePercentage
0 pure
CY2023Q1 OCTO Convertible Notes Payable Current Gross
ConvertibleNotesPayableCurrentGross
5555000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
5277250 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
626077 usd
CY2022Q4 OCTO Convertible Notes Payable Percentage
ConvertibleNotesPayablePercentage
0 pure
CY2023Q1 OCTO Convertible Notes Payable Non Current Gross
ConvertibleNotesPayableNonCurrentGross
2000000 usd
CY2022Q4 OCTO Convertible Notes Payable Non Current Gross
ConvertibleNotesPayableNonCurrentGross
9743333 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
316120 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
1831828 usd
CY2023Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1683880 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
7911505 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1793458 usd
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1793458 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4532673 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4335611 usd
CY2023Q1 OCTO Loss On Issuance Of Warrants
LossOnIssuanceOfWarrants
197061 usd
CY2023Q1 OCTO Warrant Modification Expense
WarrantModificationExpense
664389 usd
CY2023Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
277750 usd
CY2023Q1 OCTO Warrants Share Price
WarrantsSharePrice
0.12
CY2023Q1 OCTO Convertible Notes Payable Related Party Percentage
ConvertibleNotesPayableRelatedPartyPercentage
0.10 pure
CY2022Q4 OCTO Convertible Notes Payable Related Party Percentage
ConvertibleNotesPayableRelatedPartyPercentage
0.10 pure
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-189997 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4150207 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 OCTO Stock Issued During Period Shares Issued To Note Holders
StockIssuedDuringPeriodSharesIssuedToNoteHolders
774733 shares
CY2023Q1 OCTO Stock Issued During Period Value Issued To Note Holders
StockIssuedDuringPeriodValueIssuedToNoteHolders
7743333 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
20550 shares
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
571200 usd
CY2023Q1 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2023-01-17
CY2023Q1 us-gaap Preferred Stock Dividend Preference Or Restrictions
PreferredStockDividendPreferenceOrRestrictions
the board of directors of the Company declared a dividend of one one-thousandth of a share of Series A Preferred Stock
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-01-27
CY2023Q1 us-gaap Payments For Rent
PaymentsForRent
345720 usd
CY2022Q1 us-gaap Payments For Rent
PaymentsForRent
33700 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
609000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15889715 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
14070623 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
1819092 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3530339 usd
CY2023Q1 us-gaap Revenues
Revenues
15889715 usd
CY2023Q1 OCTO Capital Expenditures
CapitalExpenditures
36308 usd
CY2023Q1 us-gaap Assets
Assets
60754386 usd

Files In Submission

Name View Source Status
octo-20230331_pre.xml Edgar Link unprocessable
0001493152-23-017616-index-headers.html Edgar Link pending
0001493152-23-017616-index.html Edgar Link pending
0001493152-23-017616.txt Edgar Link pending
0001493152-23-017616-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
octo-20230331.xsd Edgar Link pending
octo-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
octo-20230331_def.xml Edgar Link unprocessable
octo-20230331_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending